Annual EBITDA
-$93.49 M
+$4.09 M+4.19%
December 31, 2023
Summary
- As of March 8, 2025, OMGA annual EBITDA is -$93.49 million, with the most recent change of +$4.09 million (+4.19%) on December 31, 2023.
- During the last 3 years, OMGA annual EBITDA has fallen by -$65.97 million (-239.67%).
- OMGA annual EBITDA is now -464.69% below its all-time high of -$16.56 million, reached on December 31, 2019.
Performance
OMGA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$13.32 M
+$2.65 M+16.57%
September 30, 2024
Summary
- As of March 8, 2025, OMGA quarterly EBITDA is -$13.32 million, with the most recent change of +$2.65 million (+16.57%) on September 30, 2024.
- Over the past year, OMGA quarterly EBITDA has increased by +$5.31 million (+28.52%).
- OMGA quarterly EBITDA is now -165.99% below its all-time high of -$5.01 million, reached on March 31, 2020.
Performance
OMGA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$66.84 M
+$7.72 M+10.35%
September 30, 2024
Summary
- As of March 8, 2025, OMGA TTM EBITDA is -$66.84 million, with the most recent change of +$7.72 million (+10.35%) on September 30, 2024.
- Over the past year, OMGA TTM EBITDA has increased by +$20.77 million (+23.71%).
- OMGA TTM EBITDA is now -1234.68% below its all-time high of -$5.01 million, reached on March 31, 2020.
Performance
OMGA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
OMGA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.2% | +28.5% | +23.7% |
| 3 y3 years | -239.7% | +28.5% | +23.7% |
| 5 y5 years | -464.7% | +28.5% | +23.7% |
OMGA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -44.6% | +4.2% | at high | +55.1% | -2.8% | +38.0% |
| 5 y | 5-year | -464.7% | +4.2% | -166.0% | +55.1% | -1234.7% | +38.0% |
| alltime | all time | -464.7% | +4.2% | -166.0% | +55.1% | -1234.7% | +38.0% |
Omega Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$13.32 M(-16.6%) | -$66.84 M(-10.4%) |
| Jun 2024 | - | -$15.97 M(-14.3%) | -$74.56 M(-14.9%) |
| Mar 2024 | - | -$18.64 M(-1.5%) | -$87.61 M(-6.3%) |
| Dec 2023 | -$93.49 M(-4.2%) | -$18.92 M(-10.1%) | -$93.49 M(-10.3%) |
| Sep 2023 | - | -$21.04 M(-27.5%) | -$104.22 M(-3.4%) |
| Jun 2023 | - | -$29.02 M(+18.4%) | -$107.85 M(+4.3%) |
| Mar 2023 | - | -$24.51 M(-17.3%) | -$103.35 M(+5.9%) |
| Dec 2022 | -$97.58 M | -$29.65 M(+20.2%) | -$97.58 M(+10.6%) |
| Sep 2022 | - | -$24.66 M(+0.6%) | -$88.20 M(+9.7%) |
| Jun 2022 | - | -$24.53 M(+30.9%) | -$80.40 M(+13.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$18.73 M(-7.6%) | -$70.75 M(+8.9%) |
| Dec 2021 | -$64.64 M(+134.9%) | -$20.28 M(+20.3%) | -$64.99 M(+21.4%) |
| Sep 2021 | - | -$16.86 M(+13.3%) | -$53.55 M(+20.4%) |
| Jun 2021 | - | -$14.88 M(+14.7%) | -$44.47 M(+25.3%) |
| Mar 2021 | - | -$12.97 M(+46.7%) | -$35.49 M(+28.9%) |
| Dec 2020 | -$27.52 M(+66.2%) | -$8.84 M(+13.8%) | -$27.52 M(+47.3%) |
| Sep 2020 | - | -$7.77 M(+31.6%) | -$18.68 M(+71.2%) |
| Jun 2020 | - | -$5.90 M(+17.9%) | -$10.91 M(+117.9%) |
| Mar 2020 | - | -$5.01 M | -$5.01 M |
| Dec 2019 | -$16.56 M | - | - |
FAQ
- What is Omega Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Omega Therapeutics?
- What is Omega Therapeutics annual EBITDA year-on-year change?
- What is Omega Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Omega Therapeutics?
- What is Omega Therapeutics quarterly EBITDA year-on-year change?
- What is Omega Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Omega Therapeutics?
- What is Omega Therapeutics TTM EBITDA year-on-year change?
What is Omega Therapeutics annual EBITDA?
The current annual EBITDA of OMGA is -$93.49 M
What is the all time high annual EBITDA for Omega Therapeutics?
Omega Therapeutics all-time high annual EBITDA is -$16.56 M
What is Omega Therapeutics annual EBITDA year-on-year change?
Over the past year, OMGA annual EBITDA has changed by +$4.09 M (+4.19%)
What is Omega Therapeutics quarterly EBITDA?
The current quarterly EBITDA of OMGA is -$13.32 M
What is the all time high quarterly EBITDA for Omega Therapeutics?
Omega Therapeutics all-time high quarterly EBITDA is -$5.01 M
What is Omega Therapeutics quarterly EBITDA year-on-year change?
Over the past year, OMGA quarterly EBITDA has changed by +$5.31 M (+28.52%)
What is Omega Therapeutics TTM EBITDA?
The current TTM EBITDA of OMGA is -$66.84 M
What is the all time high TTM EBITDA for Omega Therapeutics?
Omega Therapeutics all-time high TTM EBITDA is -$5.01 M
What is Omega Therapeutics TTM EBITDA year-on-year change?
Over the past year, OMGA TTM EBITDA has changed by +$20.77 M (+23.71%)